These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3158183

  • 1. Lack of efficacy of nafazatrom, a novel anti-thrombotic compound, in patients with coronary artery disease.
    Roy L, Mehta J, Mehta P.
    Am Heart J; 1985 May; 109(5 Pt 1):1026-31. PubMed ID: 3158183
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.
    Buchanan MR, Butt RW, Turpie AG.
    Am Heart J; 1987 May; 113(5):1133-7. PubMed ID: 2953219
    [Abstract] [Full Text] [Related]

  • 5. In vivo and in vitro effects of nafazatrom (Bay g 6575), an antithrombotic compound, on arachidonic acid metabolism in platelets and vascular tissue.
    Fischer S, Struppler M, Weber PC.
    Biochem Pharmacol; 1983 Jul 15; 32(14):2231-6. PubMed ID: 6688182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of treadmill and pacing stress testing on peripheral arterial thromboxane, platelet function and catecholamine activities in patients with chronic coronary artery disease.
    Kurita A, Satomura K, Takase B, Sugawara H, Hosono K.
    Jpn J Med; 1987 Feb 15; 26(1):7-14. PubMed ID: 2952824
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
    Fujinishi A, Takahara K, Ohba C, Nakashima Y, Kuroiwa A.
    Angiology; 1997 Jun 15; 48(6):515-21. PubMed ID: 9194537
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effects of nafazatrom on ischemic reperfused myocardium.
    Shea MJ, Murtagh JJ, Jolly SR, Abrams GD, Pitt B, Lucchesi BR.
    Eur J Pharmacol; 1984 Jun 15; 102(1):63-70. PubMed ID: 6479219
    [Abstract] [Full Text] [Related]

  • 12. The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.
    Fiedler VB.
    Basic Res Cardiol; 1983 Jun 15; 78(3):266-80. PubMed ID: 6615399
    [Abstract] [Full Text] [Related]

  • 13. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
    Yu Z, Chen KJ.
    Zhong Xi Yi Jie He Za Zhi; 1987 Jan 15; 7(1):8-11, 3. PubMed ID: 2954711
    [No Abstract] [Full Text] [Related]

  • 14. Clinical study of a new antimetastatic compound, Nafazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer.
    Warrell RP, Bockman RS, Staszewski H, Maiese K.
    Cancer; 1986 Apr 15; 57(8):1455-60. PubMed ID: 2936443
    [Abstract] [Full Text] [Related]

  • 15. Manipulation of the local thromboxane and prostacyclin balance in vivo by the antithrombotic compounds dazoxiben, acetylsalicylic acid and nafazatrom.
    Deckmyn H, Van Houtte E, Verstraete M, Vermylen J.
    Biochem Pharmacol; 1983 Sep 15; 32(18):2757-62. PubMed ID: 6578796
    [Abstract] [Full Text] [Related]

  • 16. Effects of nafazatrom and indomethacin on experimental myocardial ischemia in the anesthetized dog.
    Fiedler VB, Mardin M.
    J Cardiovasc Pharmacol; 1985 Sep 15; 7(5):983-9. PubMed ID: 2413312
    [Abstract] [Full Text] [Related]

  • 17. Failure of percutaneous transluminal coronary angioplasty to stimulate platelet and prostaglandin activity.
    Stine RA, Magorien RD, Bush CA, Kolibash AJ, Leier CV, Fertel RH, Brandt J, Unverferth DV.
    Cathet Cardiovasc Diagn; 1985 Sep 15; 11(3):247-54. PubMed ID: 3160477
    [Abstract] [Full Text] [Related]

  • 18. [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in rabbits under acute experimental cerebral ischemia].
    Liu Z.
    Zhong Xi Yi Jie He Za Zhi; 1990 Sep 15; 10(9):543-4, 517-8. PubMed ID: 2148509
    [Abstract] [Full Text] [Related]

  • 19. Effect of felodipine, a new calcium channel antagonist, on platelet function and fibrinolytic activity at rest and after exercise.
    Sengeløv H, Winther K.
    Eur J Clin Pharmacol; 1989 Sep 15; 37(5):453-7. PubMed ID: 2532135
    [Abstract] [Full Text] [Related]

  • 20. [Effects of Ligusticum wallichii on the plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2 and 6-keto-PGF1 alpha in patients with acute cerebral infarction].
    Liu Z.
    Zhong Xi Yi Jie He Za Zhi; 1991 Dec 15; 11(12):711-3, 707. PubMed ID: 1840363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.